A retrospective study on the pathological diagnostic ability of endoscopic tissue sampling for biliary tract diseases

A retrospective study on the pathological diagnostic ability of endoscopic tissue sampling for biliary tract diseases - A retrospective study on the pathological diagnostic ability of endoscopic tissue sampling for biliary tract diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033652

Enrollment

Registered

2018-08-07

Start date

2018-08-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholangiocarcinoma benign biliary stricture

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women aged 20 years or older at the time of performing the endoscopic procedure. Patients who underwent pathologic diagnosis for biliary tract mass and / or bile duct stricture.

Exclusion criteria

Exclusion criteria: Patients who were refused to participate in the opt-out poster. Patients recieved medication for malignant tumor within 1 month prior to acquiring the pathological specimen. Patients whom researcher considered inappropriate.

Design outcomes

Primary

Measure	Time frame
To evaluate diagnostic performances of EUS-FNA and ERCP tissue sampling based on pathological evaluation.	—

Secondary

Measure	Time frame
To evaluate the adverse events of EUS-FNA, ERCP for biliary tract disease. To evaluate the factors related to accuracy of EUS-FNA, ERCP tissue sampling for biliary tract cancer.	—

Countries

Japan

Contacts

Public ContactTakumi Onoyama

Faculty of Medicine, Tottori University Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine

golf4to@yahoo.co.jp0859-38-6527

Outcome results